DALLAS, Nov. 4, 2005 (PRIMEZONE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site has initiated profile coverage of Meridian Co. Ltd. ("Meridian") (OTCBB:MRDAF). The Company is engaged in the research, development, manufacturing and sales of medical devices for the natural and alternative medicine industries.
The company's products cross all boundaries of health care disciplines and are useful in the practice of medicine, osteopathy, homeopathy, naturopathy, acupuncture and other complementary disciplines. If stress or imbalance is detected in a patient, their products can identify the meridian imbalances in a person's body and assist the practitioner in a course of treatment or therapy to alleviate the stress or to restore balance to the body's meridian systems.
To view the StockGuru.com Profile for Meridian, please visit: http://www.stockguru.com/profiles/mrdaf/index.php
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/stocks.htm
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031 or email publisher@stockguru.com.
About Meridian
Meridian is an established leader in the research/development, manufacturing and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.
Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.
This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the company.
Disclosure: Pentony Enterprises LLC was compensated up to $10,000 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.